More positive coverage
Impedimed has flagged potential new markets for its device, such as monitoring a build up of heart fluid.
"This is a much larger potential market, therefore 2016 could be transformational for Impedimed," Smith said, where he has a $1.90 price target.
http://www.theage.com.au/business/m...l-biotechs-20151228-glvrek.html#ixzz3wHBpEj77
- Forums
- ASX - By Stock
- trending upwards
More positive coverage Impedimed has flagged potential new...
Featured News
Add IPD (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
-0.003(4.69%) |
Mkt cap ! $123.4M |
Open | High | Low | Value | Volume |
6.4¢ | 6.4¢ | 6.1¢ | $195.2K | 3.155M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 183833 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 183833 | 0.061 |
6 | 292846 | 0.060 |
4 | 173500 | 0.059 |
3 | 211724 | 0.058 |
3 | 37222 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 80000 | 1 |
0.066 | 249356 | 1 |
0.067 | 420000 | 1 |
0.068 | 77889 | 1 |
0.069 | 90928 | 1 |
Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online